ANSI/HL7 V3 DSR, R 2-2011
HL7版本3标准:药物稳定性报告,(eStability),版本2

HL7 Version 3 Standard: Drug Stability Reporting, (eStability), Release 2

ANSI/HL7 V3 DSR, R 2-2011 发布历史

The specification is designed to capture the contents of a stability report to be submitted to a national regulatory agency. The primary point of reference is current stability reporting within the United States. The scope of a single transaction/message in this specification has been restricted to studies with a single set of storage conditions. Studies that require multiple storage conditions and or orientations (e.g., accelerated, room temperature, inverted, upright, etc.), will be handled through the submission of multiple linked reports, with each report covering a single storage condition and orientation.

ANSI/HL7 V3 DSR, R 2-2011由美国国家标准学会 US-ANSI 发布于 2011。

ANSI/HL7 V3 DSR, R 2-2011 在中国标准分类中归属于: C10 医药综合，在国际标准分类中归属于: 11.120.10 药物。

ANSI/HL7 V3 DSR, R 2-2011的历代版本如下：

• 2011年 ANSI/HL7 V3 DSR, R 2-2011 HL7版本3标准:药物稳定性报告,(eStability),版本2

非常抱歉，我们暂时无法提供预览，您可以试试： 免费下载 ANSI/HL7 V3 DSR, R 2-2011 前三页，或者稍后再访问。

注意： 点击下载后，生成下载文件时间比较长，请耐心等待......

标准号

ANSI/HL7 V3 DSR, R 2-2011

发布日期

2011年

实施日期

废止日期

无

中国标准分类号

C10

国际标准分类号

11.120.10

发布单位

US-ANSI

被代替标准

ANSI/HL7 V3 DSR, R 1-2005

适用范围

The specification is designed to capture the contents of a stability report to be submitted to a national regulatory agency. The primary point of reference is current stability reporting within the United States. The scope of a single transaction/message in this specification has been restricted to studies with a single set of storage conditions. Studies that require multiple storage conditions and or orientations (e.g., accelerated, room temperature, inverted, upright, etc.), will be handled through the submission of multiple linked reports, with each report covering a single storage condition and orientation.